Literature DB >> 24342719

Oxidative stress in melanocyte senescence and melanoma transformation.

Svenja Meierjohann1.   

Abstract

Melanoma is a severe type of skin cancer with a high metastasis potential and poor survival rates once metastasized. The causes of melanoma formation are multifactorial and not fully understood. Several signaling cascades such as the RAS/RAF/ERK1/2 pathway, the PI3K/AKT pathway, RAC1 and NF-κB are involved in melanoma initiation and progression. Reactive oxygen species (ROS) are induced by these signal transduction cascades, and they play a fundamental role in melanomagenic processes. Cells derived from the melanocytic lineage are particularly sensitive to an increase in ROS, and thus, melanoma cells rely on efficient antioxidant measures. This review summarizes the causes and consequences of ROS generation in melanocytes and melanoma and discusses the potential of pro-oxidant therapy in melanoma treatment.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; Melanocytes; Melanoma; Reactive oxygen species; Senescence; Transsulfuration pathway

Mesh:

Substances:

Year:  2013        PMID: 24342719     DOI: 10.1016/j.ejcb.2013.11.005

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  27 in total

Review 1.  Pathways from senescence to melanoma: focus on MITF sumoylation.

Authors:  J Leclerc; R Ballotti; C Bertolotto
Journal:  Oncogene       Date:  2017-08-21       Impact factor: 9.867

Review 2.  Autophagy: In the cROSshairs of cancer.

Authors:  Heather Graham Hambright; Rita Ghosh
Journal:  Biochem Pharmacol       Date:  2016-10-24       Impact factor: 5.858

Review 3.  Targeting mitochondrial metabolism for metastatic cancer therapy.

Authors:  Antonino Passaniti; Myoung Sook Kim; Brian M Polster; Paul Shapiro
Journal:  Mol Carcinog       Date:  2022-06-20       Impact factor: 5.139

Review 4.  Hypoxia-independent drivers of melanoma angiogenesis.

Authors:  Svenja Meierjohann
Journal:  Front Oncol       Date:  2015-05-05       Impact factor: 6.244

5.  In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.

Authors:  C Leikam; A L Hufnagel; C Otto; D J Murphy; B Mühling; S Kneitz; I Nanda; M Schmid; T U Wagner; S Haferkamp; E-B Bröcker; M Schartl; S Meierjohann
Journal:  Cell Death Dis       Date:  2015-04-02       Impact factor: 8.469

6.  Regulation of NADPH-dependent Nitric Oxide and reactive oxygen species signalling in endothelial and melanoma cells by a photoactive NADPH analogue.

Authors:  Florian Rouaud; Miguel Romero-Perez; Huan Wang; Irina Lobysheva; Booma Ramassamy; Etienne Henry; Patrick Tauc; Damien Giacchero; Jean-Luc Boucher; Eric Deprez; Stéphane Rocchi; Anny Slama-Schwok
Journal:  Oncotarget       Date:  2014-11-15

7.  Reactivation of p53 by a Cytoskeletal Sensor to Control the Balance Between DNA Damage and Tumor Dissemination.

Authors:  Cecilia Herraiz; Fernando Calvo; Pahini Pandya; Gaia Cantelli; Irene Rodriguez-Hernandez; Jose L Orgaz; NaRa Kang; Tinghine Chu; Erik Sahai; Victoria Sanz-Moreno
Journal:  J Natl Cancer Inst       Date:  2015-10-13       Impact factor: 13.506

Review 8.  Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes.

Authors:  Zhuhui Qiao; Xiuxiu Wang; Leihong Xiang; Chengfeng Zhang
Journal:  Oxid Med Cell Longev       Date:  2016-11-29       Impact factor: 6.543

9.  Photodynamic Treatment of Oral Squamous Cell Carcinoma Cells with Low Curcumin Concentrations.

Authors:  Kim Beyer; Frangis Nikfarjam; Manuel Butting; Markus Meissner; Anke König; Ana Ramirez Bosca; Roland Kaufmann; Detlef Heidemann; August Bernd; Stefan Kippenberger; Nadja Zöller
Journal:  J Cancer       Date:  2017-05-11       Impact factor: 4.207

10.  Paraquat Induces Apoptosis through Cytochrome C Release and ERK Activation.

Authors:  Hong Joo Seo; Sang Joon Choi; Jung-Hee Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-11-30       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.